Use the column to the left to read important details and topics regarding each service in particular
We ecourage you to contact Ocean Blue Medical Research Center for more questions and/or information about our services.
The United States Food and Drug Administration (FDA) defines bioequivalence as:
Ocean Blue Medical Research Center' comprehensive services for bioequivalence studies include protocol design and development, clinical conduct, bioanalysis and statistical analysis.
Our final study reports for FDA submission are produced using Liquent InSight Publisher®, which automatically compiles source documents with varying file formats into one seamless publication. This technology also supports reporting from Thermo Electron Watson® LIMS and other software.